ESPL1 and cancer: Through the use of public data mining, we were able to confirm that ESPL1 is an oncogene, that it can serve as a prognostic marker for several cancers, that it can be used to direct cancer medication therapy in patient derived organoids, and that ESPL1 knockdown can limit cell growth in vitro.